{"resourceType":"ValueSet","id":"genetic-therapeutic-implications-vs","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <a href=\"http://loinc.org\"><code>http://loinc.org</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA10315-2.html\">LA10315-2</a></td><td>Ultrarapid metabolizer</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25391-6.html\">LA25391-6</a></td><td>Normal metabolizer</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25390-8.html\">LA25390-8</a></td><td>Rapid metabolizer</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA10317-8.html\">LA10317-8</a></td><td>Intermediate metabolizer</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA9657-3.html\">LA9657-3</a></td><td>Poor metabolizer</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA19542-2.html\">LA19542-2</a></td><td>Low Risk</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA19541-4.html\">LA19541-4</a></td><td>High Risk</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA6676-6.html\">LA6676-6</a></td><td>Resistant</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA6677-4.html\">LA6677-4</a></td><td>Responsive</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA9660-7.html\">LA9660-7</a></td><td>Presumed resistant</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA9661-5.html\">LA9661-5</a></td><td>Presumed responsive</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA6682-4.html\">LA6682-4</a></td><td>Unknown Significance</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA6675-8.html\">LA6675-8</a></td><td>Benign</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA6674-1.html\">LA6674-1</a></td><td>Presumed Benign</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA9662-3.html\">LA9662-3</a></td><td>Presumed non-responsive</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25392-4.html\">LA25392-4</a></td><td>Increased function</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25393-2.html\">LA25393-2</a></td><td>Normal function</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25395-7.html\">LA25395-7</a></td><td>Decreased function</td></tr><tr><td><a href=\"http://details.loinc.org/LOINC/LA25394-0.html\">LA25394-0</a></td><td>Poor function</td></tr></table></li><li>Include these codes as defined in <a href=\"http://www.snomed.org/\"><code>http://snomed.info/sct</code></a><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href=\"http://snomed.info/id/444734003\">444734003</a></td><td>Does not meet eligibility criteria for clinical trial (finding)</td></tr><tr><td><a href=\"http://snomed.info/id/399223003\">399223003</a></td><td>Patient eligible for clinical trial (finding)</td></tr></table></li></ul></div>"},"url":"http://hl7.org/fhir/uv/genomics-reporting/ValueSet/genetic-therapeutic-implications-vs","version":"2.0.0","name":"GeneticTherapeuticImplicationsVS","title":"Genetic Therapeutic Implications","status":"active","date":"2022-05-09T16:53:07+00:00","publisher":"HL7 Clinical Genomics Working Group","contact":[{"name":"HL7 Clinical Genomics Working Group","telecom":[{"system":"url","value":"http://www.hl7.org/Special/committees/clingenomics"},{"system":"email","value":"cg@lists.HL7.org"}]}],"description":"Value Set for terms that describe a predicted ramification based on the presence of associated molecular finding(s).","jurisdiction":[{"coding":[{"system":"http://unstats.un.org/unsd/methods/m49/m49.htm","code":"001","display":"World"}]}],"copyright":"This material contains content from LOINC (http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license. LOINC® is a registered United States trademark of Regenstrief Institute, Inc.\nThis value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement.","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"LA10315-2","display":"Ultrarapid metabolizer"},{"code":"LA25391-6","display":"Normal metabolizer"},{"code":"LA25390-8","display":"Rapid metabolizer"},{"code":"LA10317-8","display":"Intermediate metabolizer"},{"code":"LA9657-3","display":"Poor metabolizer"},{"code":"LA19542-2","display":"Low Risk"},{"code":"LA19541-4","display":"High Risk"},{"code":"LA6676-6","display":"Resistant"},{"code":"LA6677-4","display":"Responsive"},{"code":"LA9660-7","display":"Presumed resistant"},{"code":"LA9661-5","display":"Presumed responsive"},{"code":"LA6682-4","display":"Unknown Significance"},{"code":"LA6675-8","display":"Benign"},{"code":"LA6674-1","display":"Presumed Benign"},{"code":"LA9662-3","display":"Presumed non-responsive"},{"code":"LA25392-4","display":"Increased function"},{"code":"LA25393-2","display":"Normal function"},{"code":"LA25395-7","display":"Decreased function"},{"code":"LA25394-0","display":"Poor function"}]},{"system":"http://snomed.info/sct","concept":[{"code":"444734003","display":"Does not meet eligibility criteria for clinical trial (finding)"},{"code":"399223003","display":"Patient eligible for clinical trial (finding)"}]}]}}